Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells

Human Immunology

Volumn 59, Issue 11, 1998, Pages 700-712

  Young, Neil T ^a,b   Rust, Nigel A ^a   Dallman, Margaret J ^c   Cerundolo, Vincenzo ^d   Morris, Peter J ^a   Welsh, Ken I ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; EPITOPE; HLA ANTIGEN CLASS 1;

ALLOIMMUNITY; ARTICLE; CELL SPECIFICITY; CYTOTOXICITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MONONUCLEAR CELL; NATURAL KILLER CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD94; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FLOW CYTOMETRY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-D ANTIGENS; HUMANS; ISOANTIGENS; KILLER CELLS, NATURAL; LECTINS; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 0031671084     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00078-0     Document Type: Article

References (50)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187.
2. Lanier L.L., Phillips J.H. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today. 17:1996;86.
3. Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M.C., Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 155:1997;105.
4. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in clones displaying different specificities . J Exp Med. 178:1993;597.
5. Colonna M., Brooks E.G., Falco M., Ferrara G.B., Strominger J.L. Generation of allospecific natural killer cells across a polymorphism of HLA-C. Science. 260:1993;1121.
6. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405.
7. Dohring C., Scheidegger D., Samaridis J., Cella M., Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol. 156:1996;3098.
8. Selvakumar A., Steffens U., Dupont B. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens. 48:1996;285.
9. Carretero M., Cantoni C., Bellon T., Bottino C., Biassoni R., Rodriguez A., Perez-Villar J.J., Moretta L., Moretta A., Lopez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563.
10. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 158:1997;3603.
11. Braud V., Allan D.S.J., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795.
12. Soderstrom K., Corliss B., Lanier L.L., Phillips J.H. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol. 159:1997;1072.
13. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., Bottino C., Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875.
14. Spits H., Lanier L.L., Phillips J.H. Development of human T and natural killer cells. Blood. 85:1995;2654.
15. Gumperz J.E., Valiante N.M., Parham P., Lanier L.L., Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appears genetically regulated but not linked to major histocompatibility complex haplotype. J Exp Med. 183:1996;1817.
16. Lanier L.L., Gumperz J.E., Parham P., Melero I., Lopez-Botet M., Phillips J.H. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol. 154:1995;3320.
17. Young N.T., Bunce M., Morris P.J., Welsh K.I. Killer cell inhibitory receptor interactions with HLA class I molecules - implications for alloreactivity and transplantation. Hum Immunol. 52:1997;1.
18. Bunce M., O'Neill C.M., Barnardo M.C.N.M., Krausa P., Browning M.J., Morris P.J., Welsh K.I. Phototyping comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP) . Tissue Antigens. 46:1995;355.
19. Parham P., Adams E.J., Arnett K.L. The origins of HLA-A, B,C polymorphism. Immunol Rev. 143:1995;141.
20. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Wiedenbach K., Corliss B., Tyan D., Lanier L.L., Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:1997;753.
21. DeMars R., Chang C., Shaw S., Reitnauer P.J., Sondel P.M. Homozygous deletions that simultaneously eliminate expression of class I and class II antigens of EBV-transformed B-lymphoblastoid cells I Reduced proliferation responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens . Hum Immunol. 11:1984;77.
22. Cerundolo V., Kelly A., Elliott T., Trowsdale J., Townsend A. Genes in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol. 25:1995;554.
23. Salter R.D., Howell D.N., Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:1985;235.
24. Litwin V., Gumperz J., Parham P., Phillips J.H., Lanier L.L. NKB1 a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules . J Exp Med. 180:1994;537.
25. Moretta A., Tambusi G., Bottino C., Tripodi G., Merli A., Ciccone E., Pantaleo G., Moretta L. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. J Exp Med. 171:1990;695.
26. Aramburu J., Balboa M.A., Ramirez A., Silva A., Acevedo A., Sanchez-Madrid F., Landazuri M.O.D., Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor γ/δ+ T lymphocytes I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody . J Immunol. 144:1990;3238.
27. Storkus W.J., Howell D.N., Salter R.D., Dawson J.R., Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol. 138:1987;1657.
28. Steinle A., Schendel D.J. HLA class I alleles of LCL 721 and 174xCEM.T2(T2). Tissue Antigens. 44:1994;268.
29. Young NT, Mulder A, Cerundolo V, Claas FHJ, Welsh KI: Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens in press.
30. Braud V., Allan D.S.J., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E expression correlates with the binding of an MHC class I leader peptide. Curr Biol. 8:1998;1.
31. Litwin V., Gumperz J., Parham P., Phillips J.H., Lanier L.L. Specificity of HLA Class I antigen recognition by human NK clones evidence for clonal heterogeneity, protection by self and non-self alleles and influence of the target cell type . J Exp Med. 178:1993;1321.
32. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Wiedenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7:1997;739.
33. McCutcheon J.A., Gumperz J., Smith K.D., Lutz C.T., Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med. 181:1995;2085.
34. Salcedo M., Momburg F., Hammerling G.J., Ljunggren H.G. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. J Immunol. 152:1994;1702.
35. Suto Y., Maenaka K., Yabe T., Hirai M., Tokunaga K., Tadokoro K., Juji T. Chromosomal localization of the human natural killer cell class I receptor family genes to 19q13 4 by fluorescence in situ hybridization . Genomics. 35:1996;270.
36. Suto Y., Yabe T., Maenaka K., Tokunaga K., Tadokoro K., Juji T. The human natural killer gene complex (NKC) is located on chromosome 12p13.1-p13.2. Immunogenetics. 46:1997;159.
37. Colonna M., Navarro F., Bellón T., Llano M., García P., Samaridis J., Angman L., Cella M., López-Botet M. A common inhibitory receptor for Major Histocompatibility Complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809.
38. Cambiaggi A., Verthuy C., Naquet P., Romagne F., Ferrier P., Biassoni R., Moretta A., Moretta L., Vivier E. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b). Proc Natl Acad Sci USA. 94:1997;8088.
39. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095.
40. Peruzzi M., Parker K.C., Long E.O., Malnati M.S. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol. 157:1996;3350.
41. Rajagopalan S., Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med. 185:1997;1523.
42. Strom T.B., Tilney N.L., Carpenter C.B., Busch G.J. Identity and cytotoxic capacity of cells infiltrating renal allografts. New Engl J Med. 292:1975;1257.
43. Niederwieser D., Gastl G., Rumpold H., Marth C., Kraft D., Huber C. Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haem. 65:1987;301.
44. George T., Yu Y.Y.L., Liu J., Davenport C., Lemieux S., Stoneman E., Mathew P.A., Kumar V., Bennett M. Allorecognition by murine natural killer cells lysis of T lymphoblasts and rejection of bone marrow grafts . Immunol Rev. 155:1997;29.
45. Petersson E., Ostrat O., Ekberg H., Hansson J., Simanaitas M., Brodin T., Dohlsten M., Hedlund G. Allogeneic heart transplantation activates alloreactive NK cells. Cell Immunol. 175:1997;25.
46. Albi N., Ruggeri L., Aversa F., Merigiola C., Tosti A., Tognellini R., Grossi C.E., Martelli M.F., Velardi A. Natural killer (NK)-cell function and antileukaemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation. Blood. 87:1996;3993.
47. Bender J.R., Pardi R., Engelman E. T-cell receptor negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. Proc Natl Acad Sci USA. 87:1990;6949.
48. Paul L.L. Chronic renal transplant loss. Kidney Int. 47:1995;1491.
49. Petersdorf E.W., Longton G.M., Anasetti C., Mickelson E.M., McKinney S.K., Smith A.G., Martin P.J., Hansen J.A. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood. 89:1997;1818.
50. Borges L., Hsu M.-L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 159:1997;5192.